Page last updated: 2024-09-03

valdecoxib and Gastroduodenal Ulcer

valdecoxib has been researched along with Gastroduodenal Ulcer in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, NM; Kent, JD; Recker, DP; Sikes, DH; Verburg, KM; Zhao, WW1
Pavelka, K; Recker, DP; Verburg, KM1
Niculescu, L; Peña, B; von Scheele, B; Wong, J1
Agrawal, N; Eisen, GM; Goldstein, JL; Kent, JD; Stenson, WF; Verburg, KM1
Kellner, H1
Epstein, J; Klasser, GD1
Shaughnessy, AF1

Reviews

2 review(s) available for valdecoxib and Gastroduodenal Ulcer

ArticleYear
Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
    Alimentary pharmacology & therapeutics, 2004, Sep-01, Volume: 20, Issue:5

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Humans; Isoenzymes; Isoxazoles; Male; Membrane Proteins; Middle Aged; Multicenter Studies as Topic; Osteoarthritis; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Sulfonamides

2004
Nonsteroidal anti-inflammatory drugs: confusion, controversy and dental implications.
    Journal (Canadian Dental Association), 2005, Volume: 71, Issue:8

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Humans; Isoxazoles; Lactones; Myocardial Infarction; Peptic Ulcer; Pyrazoles; Sulfonamides; Sulfones; Toothache

2005

Trials

3 trial(s) available for valdecoxib and Gastroduodenal Ulcer

ArticleYear
Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis.
    European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Diclofenac; Double-Blind Method; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Ibuprofen; Isoenzymes; Isoxazoles; Male; Membrane Proteins; Middle Aged; Osteoarthritis; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Stomach Ulcer; Sulfonamides; Treatment Outcome

2002
Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
    Rheumatology (Oxford, England), 2003, Volume: 42, Issue:10

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; Humans; Isoenzymes; Isoxazoles; Male; Membrane Proteins; Middle Aged; Pain Measurement; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Treatment Outcome

2003
Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial.
    Rheumatology (Oxford, England), 2003, Volume: 42 Suppl 3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cohort Studies; Cost Savings; Cost-Benefit Analysis; Diclofenac; Drug Costs; Female; Health Resources; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Peptic Ulcer; Sulfonamides

2003

Other Studies

4 other study(ies) available for valdecoxib and Gastroduodenal Ulcer

ArticleYear
[Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
    MMW Fortschritte der Medizin, 2003, May-01, Volume: 145, Issue:18

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Pain; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Treatment Outcome

2003
[Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"].
    Krankenpflege Journal, 2004, Volume: 42, Issue:5-6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Drug Costs; Germany; Humans; Isoxazoles; Osteoarthritis; Peptic Ulcer; Product Surveillance, Postmarketing; Risk Factors; Sulfonamides

2004
Valdecoxib (Bextra)--a new cox-2 inhibitor.
    The Medical letter on drugs and therapeutics, 2002, Apr-29, Volume: 44, Issue:1129

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoxazoles; Kidney Diseases; Osteoarthritis; Peptic Ulcer; Sulfonamides

2002
Right ballpark, wrong base: assessing safety of NSAIDs.
    The Journal of family practice, 2002, Volume: 51, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Isoxazoles; Lactones; Naproxen; Osteoarthritis; Peptic Ulcer; Sulfonamides; Sulfones

2002